NasdaqGS:IDXXMedical Equipment
IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate
IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles.
The update allows veterinarians in the US and Canada to detect kidney disease in pets earlier through routine bloodwork.
Clinics can access SDMA testing without changing existing workflows or investing in separate assays.
The move aligns the Catalyst platform with international veterinary kidney disease guidelines.
IDEXX Laboratories focuses on...